Nanovibronix Total Liabilities 2014-2024 | NAOV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Nanovibronix total liabilities from 2014 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Nanovibronix total liabilities from 2014 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$216B
Thermo Fisher Scientific (TMO)	$205.7B
Alcon (ALC)	$44.2B
Edwards Lifesciences (EW)	$44.1B
IDEXX Laboratories (IDXX)	$37.1B
DexCom (DXCM)	$34.9B
IQVIA Holdings (IQV)	$34.2B
Mettler-Toledo (MTD)	$27.3B
Waters (WAT)	$22.6B
STERIS (STE)	$21.7B
SONOVA HOLDING (SONVY)	$19.3B
Hologic (HOLX)	$14.4B
Fresenius Medical Care AG KGaA (FMS)	$13.5B
Penumbra (PEN)	$11.7B
Sysmex ADR (SSMXY)	$11.5B
Globus Medical (GMED)	$11.5B
Masimo (MASI)	$9.5B
Glaukos (GKOS)	$8.7B
Teleflex (TFX)	$8.1B
Inari Medical (NARI)	$4.7B
Integer Holdings (ITGR)	$4.5B
PROCEPT BioRobotics (PRCT)	$3.4B
Veracyte (VCYT)	$3.2B
Nihon Kohden (NHNKY)	$2.7B
LivaNova (LIVN)	$2.6B
TransMedics (TMDX)	$2.5B
Elekta AB (EKTAY)	$2.3B
Tandem Diabetes Care (TNDM)	$2.1B
Integra LifeSciences Holdings (IART)	$1.7B
Alphatec Holdings (ATEC)	$1.5B